Moreover, synaptophysin has a limited utility in high-grade gliomas; for example, high-grade gliomas (glioblastomas and anaplastic astrocytomas) often lose synaptophysin expression as they become more undifferentiated [97], reducing its reliability as a prognostic marker in aggressive gliomas [98]. This evidence concerns the gene SYP and anaplastic astrocytoma.